• Home
  • NEW DAY MEDICINE
  • 2 (34/1) 2021
  • 4 -2 (34/1) 2021 — Kenzhaev M.L., Rizaeva M.Zh. — TACTICS OF EMERGENCY TREATMENT OF ATRIAL FIBRILLATION: A MODERN VIEW OF THE PROBLEM

4 -2 (34/1) 2021 — Kenzhaev M.L., Rizaeva M.Zh. — TACTICS OF EMERGENCY TREATMENT OF ATRIAL FIBRILLATION: A MODERN VIEW OF THE PROBLEM

TACTICS OF EMERGENCY TREATMENT OF ATRIAL FIBRILLATION: A MODERN VIEW OF THE PROBLEM

Kenzhaev M.L.,  Tashkent Regional Specialized Somatic Hospital Bukhara State Medical Institute Republican Scientific Center for Emergency Medical Aid, Bukhara Branch

Rizaeva M.Zh. Tashkent Regional Specialized Somatic Hospital Bukhara State Medical Institute Republican Scientific Center for Emergency Medical Aid, Bukhara Branch

Resume

This article is a literary review, which presents a modern view on the strategy and tactics of relieving AF attacks, indications for pharmacological cardioversion (PCV) and electrical impulse therapy (EIT). Based on the material presented, international recommendations for the management of patients with AF were taken, as well as data from a number of modern studies and our own clinical experience in the treatment of arrhythmias. The article also deals with the issues of emergency treatment of AF and expresses the author’s point of view on the results of a number of studies in this area of ​​arrhythmology.

Key words: atrial fibrillation, emergency therapy, electrical cardioversion, electrical pulse therapy, pharmacological cardioversion, antiarrhythmic drugs.

First page

22

Last page

27

For citation: Kenzhaev M.L.,  Rizaeva M.Zh. Tactics of emergency treatment of atrial fibrillation: a modern view of the problem // New Day in Medicine 2 (34/1) 22-27 https://cutt.ly/yv60Qg0

LIST OF REFERENCES

  1. Guidelines for the management of atrial fibrillation. Eur HeartJ doi: 101093/eurheart/ ehq 278.
  2. 2014 AHA/ACC/HRS Guideline for the management of patients with atrialfibrillation. Http://circ.ahajournals.org/content/ear-ly/2014/04/10/CIR.
  3. Constantini O., Stambler B. Approach to the patients with atrial fibrillation. In Gans L.I., Braunwald E. (eds). Management of cardiac arrhythmias. Hymana Press 2004; p. 75-96.
  4. Khan I.A. Single oral loading dose of propafenoneforpharmacological cardioversion of recent onset atrial fibrillation. //J Am Coll Cardiol2001; 37:542-7.
  5. Bunin Yu., Anfalova L. Efficacy of propafenone as single oral loading dose in pharmacology converting recent-onset atrialfibrilla-tion and atrialflutter. //Europace 2005; 7 (Suppl. 1): 121-2.
  6. Chevalier P., Durand-Dubief A., Burri H. Amiodarone versus placebo and class IC drugs cardioversion of recent-onset atrial fibrillation: a meta-analysis. // JACC 2003; 41:255-61.
  7. Rho R.W., Callans D.J. The management of atrial flutter. In Gans LI., BraunwaldE. (eds). Management of cardiac arrhythmias. Hymana Press 2004; p. 163-82.
  8. Camm A.J., Capucci A., Hohnloser S. et al. A randomized active-controlled study comparing the efficacy and safety of vernacalant to amiodarone in recent onset atrial fibrillation. //J Am Coll Cardiol 2010; 4:134-99.
  9. Sung R.J., Tan H.L., Karagounis L. et al. Intravenous sotalolfor the termination of supraventricular tachycardia and atrialfibrillation and flutter. //Am Heart J 1995; 129: 739-48.
  10. ESC guidelines 2011 on management of cardiovascular disease during pregnancy. Doi:101093/eurheartj/ehr 218.
  11. American heart association guidelinesfor cardiopulmonary resuscitation and emergency cardiovascular care. //Circulation 2005; 112: IV1-211.
  12. Niebauer M.J., Brewer J.E., Clung M.K. et al. Comparison of the rectilinear biphasic waveform with monophasic damped sine waveform for external cardioversion of atrial fibrillation and flutter. Am J Cardiol2004; 93:1495-9
  13. Ricard P., Vaici K., Rinaldi J.P. et al. Cardioversion of atrial fibrillation: how and when? //Eur Heart J 2003; 5 (Suppl. H): H40-H44.
  14. Botto G.L., Politi A., Bonini Wet al. External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements. Heart 1999; 82: 726-30.
  15. European heart rhythm association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. //Europace 2013; 15:625-51.
  16. Kirchhof P., Auricchio A., Bax J. et al. Outcome parameters for trials in atrial fibrillation: executive summary. Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). //Eur Heart J 2007;28:2803-2817.

file

download